Use of GHb (HbA(1c)) to screen for undiagnosed diabetes in the U.S. population

Comparative Study

W H Herman et al. Diabetes Care. 2000 Aug.

. 2000 Aug;23(8):1207-8.

doi: 10.2337/diacare.23.8.1207.

No abstract available

Comment in

Catch-22.
Davidson MB. Davidson MB. Diabetes Care. 2001 Feb;24(2):414-5. doi: 10.2337/diacare.24.2.414. Diabetes Care. 2001. PMID: 11213908 No abstract available.

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Engelgau MM, et al. Diabetes Care. 1997 May;20(5):785-91. doi: 10.2337/diacare.20.5.785. Diabetes Care. 1997. PMID: 9135943
Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring.
Kilpatrick ES, Maylor PW, Keevil BG. Kilpatrick ES, et al. Diabetes Care. 1998 Feb;21(2):261-4. doi: 10.2337/diacare.21.2.261. Diabetes Care. 1998. PMID: 9539993
Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.
Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE. Rohlfing CL, et al. Diabetes Care. 2000 Feb;23(2):187-91. doi: 10.2337/diacare.23.2.187. Diabetes Care. 2000. PMID: 10868829